Erratum: Target-Driven Design of a Coumarinyl Chalcone Scaffold Based Novel EF2 Kinase Inhibitor Suppresses Breast Cancer Growth in Vivo (ACS Pharmacol. Transl. Sci. (2021) 4:2 (926-940) DOI: 10.1021/acsptsci.1c00030)

Ferah Comert Onder, Nermin Kahraman, Esen Bellur Atici, Ali Cagir, Hakan Kandemir, Gizem Tatar, Tugba Taskin Tok, Goknur Kara, Bekir Karliga, Serdar Durdagi, Mehmet Ay, Bulent Ozpolat

Research output: Contribution to journalComment/debatepeer-review

Fingerprint

Dive into the research topics of 'Erratum: Target-Driven Design of a Coumarinyl Chalcone Scaffold Based Novel EF2 Kinase Inhibitor Suppresses Breast Cancer Growth in Vivo (ACS Pharmacol. Transl. Sci. (2021) 4:2 (926-940) DOI: 10.1021/acsptsci.1c00030)'. Together they form a unique fingerprint.

Medicine & Life Sciences